Search by Drug Name or NDC

    NDC 00597-0400-89 Cyltezo Details

    Cyltezo

    Cyltezo is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is .

    Product Information

    NDC 00597-0400
    Product ID 0597-0400_58f63d1a-fe43-4db7-b4e5-2ff15f7c07b8
    Associated GPIs
    GCN Sequence Number 084512
    GCN Sequence Number Description adalimumab-adbm SYRINGEKIT 10MG/0.2ML SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 53841
    HICL Sequence Number 044481
    HICL Sequence Number Description ADALIMUMAB-ADBM
    Brand/Generic Brand
    Proprietary Name Cyltezo
    Proprietary Name Suffix n/a
    Non-Proprietary Name adalimumab-adbm
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761058
    Listing Certified Through 2024-12-31

    Package

    NDC 00597-0400-89 (00597040089)

    NDC Package Code 0597-0400-89
    Billing NDC 00597040089
    Package 2 KIT in 1 CARTON (0597-0400-89) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET
    Marketing Start Date 2023-07-01
    NDC Exclude Flag N
    Pricing Information N/A